Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with uterine (womb), ovarian, or cervical cancer
- People whose physical functioning is rated at a certain level by their doctor (known as ECOG score 0–2, meaning able to carry out at least some daily activities — confirm with trial site)
- People with a life expectancy of more than 6 months
- People who finished at least 6 rounds of chemotherapy (using carboplatin or cisplatin along with paclitaxel) at least 3 months before joining the study
- People who are able to read and understand survey questionnaires
- People who have reported a certain level of nerve-related symptoms on a specific questionnaire (a PNQ score of C or above — confirm with trial site)
Who may not be able to join:
- People who have a tendency to bleed easily
- People with abnormal blood clotting results
- People with a low platelet count (below 50)
- People who have previously received acupuncture treatment
- People who are currently undergoing chemotherapy
- People who have a known nerve condition or pre-existing nerve damage that is not related to chemotherapy
- People who regularly take aspirin or any blood-thinning medications
- People who have an active skin infection
- People who have a pacemaker
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karen Kar Loen Prof CHAN, MBBChir (Cantab); MD (HK), Department of Obstetrics and Gynaecology, the University of Hong Kong
Phone: 852-2255 4265
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Chemotherapy Induced Peripheral Neuropathy associated quality of life measured by Functional Assessment of Cancer Therapy / Gynecologic Oncology Group - Neurotoxicity subscale (FACT/GOG-NTX) total score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.